Caitlin Stashwick

501 total citations
12 papers, 368 citations indexed

About

Caitlin Stashwick is a scholar working on Oncology, Immunology and Reproductive Medicine. According to data from OpenAlex, Caitlin Stashwick has authored 12 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Immunology and 3 papers in Reproductive Medicine. Recurrent topics in Caitlin Stashwick's work include CAR-T cell therapy research (9 papers), Virus-based gene therapy research (2 papers) and Immunotherapy and Immune Responses (2 papers). Caitlin Stashwick is often cited by papers focused on CAR-T cell therapy research (9 papers), Virus-based gene therapy research (2 papers) and Immunotherapy and Immune Responses (2 papers). Caitlin Stashwick collaborates with scholars based in United States and Switzerland. Caitlin Stashwick's co-authors include Daniel J. Powell, János L. Tanyi, Mark H. O’Hara, Jenessa B. Smith, Andrew R. Haas, Gabriela Plesa, Katarzyna Urbańska, Mathilde Poussin, Mark A. Morgan and David L. Porter and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Molecular Therapy.

In The Last Decade

Caitlin Stashwick

12 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caitlin Stashwick United States 10 295 153 76 72 63 12 368
Heather Derocher Canada 6 288 1.0× 196 1.3× 39 0.5× 65 0.9× 41 0.7× 6 406
Esther Schoutrop Sweden 7 170 0.6× 114 0.7× 33 0.4× 69 1.0× 45 0.7× 8 274
Vincent Armenio United States 8 245 0.8× 73 0.5× 44 0.6× 65 0.9× 64 1.0× 13 310
Martina Schüßler‐Lenz Germany 6 349 1.2× 127 0.8× 119 1.6× 180 2.5× 103 1.6× 9 445
Xiaoli Tian China 11 199 0.7× 117 0.8× 35 0.5× 107 1.5× 63 1.0× 15 316
Enrico Fritsche Germany 7 262 0.9× 125 0.8× 66 0.9× 149 2.1× 124 2.0× 7 405
Paraskevi Dimou United Kingdom 6 205 0.7× 108 0.7× 32 0.4× 87 1.2× 53 0.8× 8 303
Devvora Olalere United States 4 415 1.4× 138 0.9× 103 1.4× 132 1.8× 221 3.5× 4 522
Earle O. Assanah United States 2 322 1.1× 128 0.8× 95 1.3× 54 0.8× 123 2.0× 2 349
Kassondra Meyer United States 9 269 0.9× 96 0.6× 15 0.2× 123 1.7× 15 0.2× 14 355

Countries citing papers authored by Caitlin Stashwick

Since Specialization
Citations

This map shows the geographic impact of Caitlin Stashwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caitlin Stashwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caitlin Stashwick more than expected).

Fields of papers citing papers by Caitlin Stashwick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caitlin Stashwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caitlin Stashwick. The network helps show where Caitlin Stashwick may publish in the future.

Co-authorship network of co-authors of Caitlin Stashwick

This figure shows the co-authorship network connecting the top 25 collaborators of Caitlin Stashwick. A scholar is included among the top collaborators of Caitlin Stashwick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caitlin Stashwick. Caitlin Stashwick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
O’Hara, Mark H., Caitlin Stashwick, Gabriela Plesa, & János L. Tanyi. (2017). Overcoming Barriers of car T-cell Therapy in Patients with Mesothelin-Expressing Cancers. Immunotherapy. 9(9). 767–780. 12 indexed citations
2.
Tanyi, János L., Caitlin Stashwick, Gabriela Plesa, et al.. (2017). Possible Compartmental Cytokine Release Syndrome in a Patient With Recurrent Ovarian Cancer After Treatment With Mesothelin-targeted CAR-T Cells. Journal of Immunotherapy. 40(3). 104–107. 56 indexed citations
3.
Dean, Lorraine T., Xiaochen Zhang, Nawar Latif, et al.. (2016). Race-based disparities in loss of functional independence after hysterectomy for uterine cancer. Supportive Care in Cancer. 24(8). 3573–3580. 3 indexed citations
4.
Smith, Jenessa B., Evripidis Lanitis, Denarda Dangaj Laniti, et al.. (2016). Tumor Regression and Delayed Onset Toxicity Following B7-H4 CAR T Cell Therapy. Molecular Therapy. 24(11). 1987–1999. 45 indexed citations
5.
Tanyi, János L., Andrew R. Haas, Gregory L. Beatty, et al.. (2016). Anti-mesothelin chimeric antigen receptor T cells in patients with epithelial ovarian cancer.. Journal of Clinical Oncology. 34(15_suppl). 5511–5511. 30 indexed citations
6.
O’Hara, Mark H., Caitlin Stashwick, Andrew R. Haas, & János L. Tanyi. (2016). Mesothelin as a Target for Chimeric Antigen Receptor-Modified T Cells as Anticancer Therapy. Immunotherapy. 8(4). 449–460. 62 indexed citations
7.
Urbańska, Katarzyna, Caitlin Stashwick, Mathilde Poussin, & Daniel J. Powell. (2015). Follicle-Stimulating Hormone Receptor as a Target in the Redirected T-cell Therapy for Cancer. Cancer Immunology Research. 3(10). 1130–1137. 37 indexed citations
8.
Tanyi, János L., Andrew R. Haas, Gregory L. Beatty, et al.. (2015). Abstract CT105: Safety and feasibility of chimeric antigen receptor modified T cells directed against mesothelin (CART-meso) in patients with mesothelin expressing cancers. Cancer Research. 75(15_Supplement). CT105–CT105. 17 indexed citations
9.
Smith, Jenessa B., Caitlin Stashwick, & Daniel J. Powell. (2014). B7-H4 as a potential target for immunotherapy for gynecologic cancers: A closer look. Gynecologic Oncology. 134(1). 181–189. 49 indexed citations
10.
Urbańska, Katarzyna, Rachel C. Lynn, Caitlin Stashwick, et al.. (2014). Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells. Journal of Translational Medicine. 12(1). 347–347. 34 indexed citations
11.
Stashwick, Caitlin, et al.. (2011). Surgical Risk Score Predicts Suboptimal Debulking or a Major Perioperative Complication in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer. International Journal of Gynecological Cancer. 21(8). 1422–1427. 22 indexed citations
12.
Stashwick, Caitlin, Monique A. Spillman, Kian Behbakht, Susan A. Davidson, & Michael Kelly. (2010). Use of nondebulkability score to predict residual disease and surgical morbidity in ovarian cancer.. Journal of Clinical Oncology. 28(15_suppl). e15508–e15508. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026